Well, I apologize. I did have one prepared, but I was under the same impression as Monsieur LeBlanc. When we asked whether we needed to make one, we were told that it wasn't required, that we were here to answer questions.
I apologize, but I could certainly answer questions about what we're doing on prescription drug monitoring. In fact, we've done quite a lot of work to implement the recommendations of the Auditor General. I would point out that out of the 14 recommendations that were followed up on in this report, we had a satisfactory assessment in 11 of those, unsatisfactory in three. One of those was dealing with prescription drug retrospective analysis, which we have implemented and are doing, but the Auditor General noted in her report that--